CGC
CGC
NASDAQ · Pharmaceuticals

Canopy Growth Corp

$0.98
+0.01 (+1.11%)
As of Jun 22, 3:11 PM ET ·
Financial Highlights (FY 2026)
Revenue
610.36M
Net Income
-563,824,895
Gross Margin
24.5%
Profit Margin
-92.4%
Rev Growth
-10.9%
D/E Ratio
0.35
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 24.5% 24.5% 56.1% 56.1%
Operating Margin -61.9% -55.7% 13.1% 13.7%
Profit Margin -92.4% -87.8% 14.3% 14.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 610.36M 685.33M 156.52M 143.27M
Gross Profit 149.42M 167.77M 87.74M 80.31M
Operating Income -377,994,428 -381,984,039 20.57M 19.56M
Net Income -563,824,895 -569,775,887 22.40M 20.41M
Gross Margin 24.5% 24.5% 56.1% 56.1%
Operating Margin -61.9% -55.7% 13.1% 13.7%
Profit Margin -92.4% -87.8% 14.3% 14.3%
Rev Growth -10.9% -10.9% +1.7% +0.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 79.49M 79.49M 105.38M 93.00M
Total Equity 225.43M 225.43M 454.44M 415.12M
D/E Ratio 0.35 0.35 0.23 0.22
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -335,444,173 -357,817,161 28.04M 26.75M
Free Cash Flow 15.05M 13.14M